First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

Gonzalez-Martin, Antonio; Harter, Philipp; Lorusso, Domenica; Moore, Kathleen N; Oaknin Benzaquen, Ana Mazaltob; Banerjee, Susana

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Gonzalez-Martin, Antonio
dc.contributor.author	Harter, Philipp
dc.contributor.author	Lorusso, Domenica
dc.contributor.author	Moore, Kathleen N
dc.contributor.author	Oaknin Benzaquen, Ana Mazaltob
dc.contributor.author	Banerjee, Susana
dc.date.accessioned	2021-09-20T10:03:20Z
dc.date.available	2021-09-20T10:03:20Z
dc.date.issued	2020-12-11
dc.identifier.citation	Banerjee S, Gonzalez-Martin A, Harter P, Lorusso D, Moore KN, Oaknin A, et al. First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion. ESMO Open. 2020 Dec 11;5:e001110.
dc.identifier.issn	2059-7029
dc.identifier.uri	https://hdl.handle.net/11351/6331
dc.description	Inhibidors de PARP; Càncer d’ovari avançat
dc.description.sponsorship	The project is supported by an unrestricted educational grant from AstraZeneca. The authors received an honorarium for their participation in the round table from BMJ.
dc.language.iso	eng
dc.publisher	BMJ
dc.relation.ispartofseries	ESMO Open;5
dc.rights	Attribution-NonCommercial 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/
dc.source	Scientia
dc.subject	Ovaris - Càncer -Tractament
dc.subject	Inhibidors enzimàtics - Ús terapèutic
dc.subject.mesh	Ovarian Neoplasms
dc.subject.mesh	Poly(ADP-ribose) Polymerase Inhibitors
dc.title	First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1136/esmoopen-2020-001110
dc.subject.decs	neoplasias ováricas
dc.subject.decs	inhibidores de poli(ADP-ribosa) polimerasas
dc.relation.publishversion	https://doi.org/10.1136/esmoopen-2020-001110
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Banerjee S] Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK. [Gonzalez-Martin A] Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK. [Harter P] Department of Gynaecology and Gynaecological Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany. [Lorusso D] Scientific Directorate and Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy. [Moore KN] Stephenson Cancer Center, University of Oklahoma, Norman, Oklahoma, USA. [Oaknin A] Servei d’Oncologia Mèdica, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid	33310779
dc.identifier.wos	000608044000001
dc.rights.accessrights	info:eu-repo/semantics/openAccess